A current challenge for disease modeling and public health is understanding pathogen dynamics across scales since their ecology and evolution ultimately operate on several coupled scales. This is particularly true for vector-borne diseases, where within-vector, within-host, and between vector-host populations all play crucial roles in diversity and distribution of the pathogen. Despite recent modeling efforts to determine the effect of within-host virus-immune response dynamics on between-host transmission, the role of within-vector viral dynamics on disease spread is overlooked. Here we formulate an age-since-infection structured epidemic model coupled to nonlinear ordinary differential equations describing within-host immune-virus dynamics and within-vector viral kinetics, with feedbacks across these scales. We first define the within-host viral-immune response and within-vector viral kinetics dependent basic reproduction number R 0 . Then we prove that whenever R 0 < 1, the disease free equilibrium is locally asymptotically stable, and under certain biologically interpretable conditions, globally asymptotically stable. Otherwise if R 0 > 1, it is unstable and the system has a unique positive endemic equilibrium. In the special case of constant vector to host inoculum size, we show the positive equilibrium is locally asymptotically stable and the disease is weakly uniformly persistent. Furthermore numerical results suggest that within-vector-viral kinetics and dynamic inoculum size may play a substantial role in epidemics. Finally, we address how the model can be utilized to better predict the success of control strategies such as vaccination and drug treatment.
Introduction
The ecology and evolution of infectious diseases operate on several interdependent scales. This is particularly true for vector-borne diseases, where coupled within-vector, within-host, and between vector-host population dynamics together determine the diversity and distribution of the pathogen. One of the major mechanisms in determining disease abundance and virus evolution is within-vector viral kinetics [11, 35, 37 ]. Yet, from the mathematical point of view, the within-vector viral dynamics has been overlooked, and rarely studied [31, 33, 42] . There is also a serious need for an integrated modeling approach that links all scales [22] . However, traditional modeling approaches treat within-host, within-vector, and between-host pathogen dynamics as separate systems. Multi-scale mathematical models can be both an avenue for understanding the complex features displayed by vector-borne diseases and tools for targeting interventions.
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More than 17% of all infectious diseases are accounted to be vector-borne diseases, causing more than 700, 000 deaths annually world-wide according to World Health Organization (WHO). In particular, a vast majority of vector-borne vertebrate infecting viruses (arboviruses) are responsible for a number of severe diseases in humans (yellow fever (YFV), dengue (DENV), various encephalitides, etc.) and livestock (West Nile encephalomyelitis (WNV), Rift Valley fever (RVF), vesicular stomatitis, etc.). Mathematical modeling can help us understanding the impact of mechanisms behind the establishment and transmission of vector-borne viruses, which are crucial for developing effective intervention strategies.
Mosquito-borne diseases are spread when mosquitoes bite hosts and release microscopic parasites, which live in the salivary glands of the mosquitoes, into the hosts' bloodstream. In a recent work, Churcher et al. [6] show that the number of parasites each mosquito carries influences the chance of successful malaria infection. In particular, it demontrates that the more parasites present in a mosquito's salivary glands, the more likely it was to be infectious, and also the faster any infection would develop, highlighting the importance of within-mosquito viral kinetics. So far disease control authorities, including WHO (World Health Organization), has relied on the average number of potentially infectious mosquito bites per person per year. However, not every infectious mosquito bite will result in disease, and not all equally infectious. Therefore, there is an urgent need for unified models to understand how the within-vector viral kinetics can be scaled up to the host population level disease transmission.
A large number of previous studies formulate and analyze coupled nonlinear ODE models, describing population level vector-host disease spread. In a study that extensively reviewed mosquito-borne pathogen models, Reiner et al. [31] suggests that "moving forward in mosquito-borne disease modeling and addressing public health challenges will require modeling efforts on the heterogeneities such as variation in individual hosts and mosquitoes and their consequences for heterogeneous biting." Some of the previous vector-borne disease modeling studies focus on the impact of mechanisms such as temperature and rainfall on the vector population [9, 38] , or preventative measures, such as mosquito reduction strategies or personal protection [30] . Due to the extrinsic and intrinsic incubation periods and vector maturation process, time delayed vectorborne disease models have been deployed in [4, 26, 29, 10] . Dynamical properties of vector-borne diseases are also studied in age-since-host infection structured PDE models with direct transmission, time delay or reinfection [44, 25, 5, 45] . Furthermore, in within-host scale, arbovirus-immune response dynamics such as within-host DENV transmission is modeled and analyzed in [7] . Immunology is also coupled with between vector-host disease dynamic models in prior works [20, 41] . Gulbudak et al. [20] construct a multi-scale ODE-PDE hybrid model (similar to [17] ), coupling within-host viral-immune response and between vector-host disease transmission on population scale and study coevolution of both vector-borne pathogen and host. In a companion paper, Tuncer et. al. [41] fit RVF multi-scale data to the multi-scale model in [20] , and utilize identifiability analysis for the model parameters. Furthermore, in a recent work, the effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple strain pathogens is also investigated in a two strain immuno-epidemiological DENV model structured by dynamic antibody size [19] . 
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where the variable V (s) represents the pathogen concentration within an infected mosquito at infection age s; i.e. s days passed after vector infection. The parameters r v , K v represent the intrinsic pathogen growth rate within a vector, and carrying capacity, respectively. If the initial pathogen density, denoted by V h→v 0 (= V (0)) (the amount of pathogen acquired in the blood meal of an infectious host by a susceptible vector upon a bite), is less than U v , then the virus within a vector (mosquito) eventually clears. Otherwise if V h→v 0 > U v , then the viruses persist and asymptotically converge to the carrying capacity K v . The model parameters are fitted to within-mosquito WNV viral data given in [12] in Fig.2 . The Allee effect in the model refers that when host to vector inoculum size V h→v 0 is below U v (which is assume to be a small threshold size), the virus clears faster due to loss of viruses during transportation of them from foregut to mosquito midgut and mosquito immune response [35] . However when the inoculum size V h→v 0 > U v , despite the loss during transportation, due to larger initial density, it replicates faster and reaches to carrying capacity K v [13] . Here, in particular, we focus on mosquito-borne viruses such as WNV (Cx. Pipiens), DENV ( Aedes aegypti), and RVFV (most commonly transmited by the Aedes and Culex mosquitoes). Arbovirus infection of mosquitoes is generally asymptomatic and persists for the life of the vector, but the virus appears to be continually targeted by innate immune response [35] . Here for simplicity, we do not consider mosquito immune response.
Within-host viral-immune response dynamics: To capture the short-term and long-term host-immune response to pathogen (P ) introduction, we model two particular antibodies IgM (M ) and IgG (G), released by B-cell lymphocytes. The within-host infection model takes the following form ( [20, 41] ):
Note that s in (2.2) in the initial condition (P (0, s), M (0, s), G(0, s)), means that the solutions to system (2.2) depend on the vector to host inoculum size, P v→h 0 . In particular, P 0 = P v→h 0 = h(V (s, V 0 )). The solutions are denoted by P (τ, s), M (τ, s) and G(τ, s), where the time variable τ refers time-since-infection within a host, and s denotes vector infection age. Note that upon viral progression within an infected mosquito midgut, the amount of pathogen in an infected mosquito saliva dynamically changes [34] , determining the vector to host inoculum size P v→h 0 which is the amount of pathogen that is injected to a susceptible host by an infectious vector. If the mosquito has V (s, V 0 ) amount of pathogen within at the time giving a bite to a host, then we assume that the vector to host inoculum size, P v→h 0 , is a function of the amount of the pathogen within-vector, V (s, V 0 ), i.e. P v→h 0 = h(V (s, V 0 )). Here we consider h(V (s, V 0 )) =ĉV (s, V 0 ), with a constantĉ ∈ (0, 1). The intuitive assumption is that the more pathogen an infectious mosquito has within-its midgut, the more pathogen it can inject to its hosts. Furthermore, Fortuna et al. [12] displays multiple experimental data suggesting that there is a linear relationship between the amount of pathogen within a vector and the amount of pathogen in the saliva of this mosquito. We assume that the parasite replicates with a logistic growth ratef (P ) = r h (1 − P/K h ), where the parameters r h and K h represent net viral growth rate, and the carrying capacity within a host, respectively. Upon exposure to virus, the IgM immune response activates at a rate a, and decays at a rate c. The IgM immune response antibodies are responsible for rapid destruction of virus and kills the pathogen at a rate . Furthermore, B-cells switch production of IgM antibodies to IgG antibodies with a per-capita rate q [23] . The pathogen also stimulates the IgG antibody immune response that activates at a rate b and kills the pathogen at a rate δ. Yet, the IgG immune response antibodies mainly responsible for life-long immunity.
All parameters and dependent variables of this within-host model and their definitions are given in Table 2 .
, then the pathogen (within-the host) eventually clears (lim τ →∞ P (τ, s) = 0), the IgM immune response antibodies decays to zero after viral clearance, and subsequently the IgG immune memory antibodies reach a steadystate; i.e. lim τ →∞ M (τ, s) = 0 and lim τ →∞ G(τ, s) = G + , where G + > 0 depends on the initial condition; i.e. G + = z(P v→h 0 , M 0 , G 0 ).
Proof. Let P v→h 0 (= P (0, s)) > 0. By the first equation in (2.2), we obtain
where s is fixed. Without loss of generality, assume that M 0 > 0. Then ∃τ : ∂ ∂τ G(τ, s) ≥ 0 for all τ ≥τ . Therefore G(τ, s) increases for all τ ≥τ .
Then, we obtain G(τ, s) > r h δ , for all τ >τ . Therefore as τ → ∞, the RHS of the inequality (2.3) goes to zero. Then by comparison principle, we obtain lim τ →∞ P (τ, s) = 0. Thus lim τ →∞ M (τ, s) = 0. Then G(τ, s) saturates as τ → ∞; i.e lim τ →∞ G(τ, s) =Ḡ, for someḠ > 0, depending on the initial condition (P v→h 0 , M 0 , G 0 ).
Case (ii)Now suppose that G(τ , s) < r h δ . Assume that there existsτ : P (τ , s) = 0. Then we obtain that P (τ, s) = 0, for all τ >τ and lim τ →∞ M (τ, s) = 0 and lim τ →∞ G(τ, s) = G, for someḠ > 0. Now assume that P (τ, s) > 0, for all τ > 0. Then ∂ ∂τ G(τ, s) > 0, for all τ > 0. Hence there exists τ + > 0 : G(τ + ) > r δ . The rest of the proof follows the argument in case (i), completing the proof.
The structured epidemic system: To incorporate heterogeneity among vector to host inoculum size (across the vectors with different infection age), we formulate the infected host compartment as follows: 4) where i H (t, τ, s) represents the density of hosts infected at time t − τ by a vector with infection age s. In other words, i H (t, τ, s) represents the density of hosts infected at time t − τ, with an infectious mosquito with vector to host inoculum size P v→h 0 (which is a function of viral density within-the infectious vectors; i.e. P v→h 0 = h(V (s, V 0 )).) Furthermore the rates of change in the dynamics of susceptible (S H (t) ), and recovered (R H (t) ) host population size are described as follows: Vectors are the only mechanism transmitting the disease to susceptible hosts. The agesince-infection structured vector model is given by:
Vector Population
where i v (t, s) represents the density of infected vectors at time t with infection age s. The parameters related to vector dynamics are: η the birth/recruitment rate of vectors, µ the natural death rate of vectors, β H the transmission rate of infection from infected hosts to vectors. In the system (2.4)-(2.5), a portion of the susceptible hosts move to the infected compartment with a rate ∞ 0 β v (s)i v (t, s)ds through bites by infected vectors i v (t, s) with infection age s. Linking within-vector dynamics: The epidemiological parameters β H (τ, s), γ H (τ, s), and ν H (τ, s) are formulated similar to previous studies [20] (confirmed by data [22, 14] ) as follows: The data [22, 14] suggests that the transmission rate β H (τ, s) is a Holling type II function with respect to the within-host pathogen load P (τ, s), where within-host pathogen load depends on host and vector infection age: P (τ, s) = P (τ, V (s, V 0 )). The parameters a 0 and a 1 are transmission and half saturation constants, respectively. In addition, similar to previous study [20] , we formulate the recovery rate as a function of immune response G(τ, s) and inversely related to the viral load as shown in (2.6) , where c 0 is transmission constant and 0 > 0 is proportionality constant and a small number. This formulation of recovery translates into low pathogen load with sufficient IgG memory antibodies to prevent subsequent rise in pathogen load. Thus recovery rate is a decreasing function of pathogen (P ) and increasing function of IgG immune response (G). Furthermore, disease induced death rate ν is simply formulated as a linear function of P (death due to pathogen resource use), and a function of M (death due to aggressive immune response). In addition, we formulate the transmission rate from an infectious vector to susceptible host (β v (s)) as follows:
, where the parameters d 0 , d 1 are saturation and half saturation constants, respectively.
Note that the within-vector viral kinetics V (s) affects both the vector to host transmission β v (s) and vector to host inoculum size P v→h 0 , and the latter alters the within-host virus-immune dynamics, and in turn the host to vector transmission β H (τ, s). This chain of across-scale interactions effectively introduces feedback from both scales. In contrast to previous attempts of incorporating feedback between scales [15] , our approach is amenable to analysis and biologically relevant for vector-borne diseases. Although the host to vector inoculum size V h→v 0 (amount of pathogen in blood meal) can affect withinvector kinetics, the within-host dynamics are more sensitive to vector to host inoculum size. Thus we reserve the significant mathematical complexity of a two-way "infinitedimensional" feedback for potential future modeling work, and introduce a "friendly" formulation in next section (4.1) to vary the host to vector inoculum size V h→v 0 .
Analytical results
3.1. Basic properties of the system. We assume that all parameters of the model are non-negative. In addition to that, we also consider the immune model initial conditions to be nonnegative: P 0 = P v→h 0 , M 0 , G 0 ≥ 0. Through this article, it satisfies that
Integrating the second equation of the system (2.4)-(2.5) along the characteristic lines, we obtain
where π H (τ, s) can be interpreted as the probability of host (whom is bitten with a vector at infection age s) still being in the infected class at host infection age τ. First note that by the equation (3.2), we have lim τ →∞ i H (t, τ, s) = 0, ∀ t ∈ [0, ∞). Then by integrating both side of the equation (2.4) with respect to both independent variables s and τ, we obtain the following equation:
Similarly, integrating the last equation of the system (2.4)-(2.5) along the characteristic lines, we obtain
where π v (s) can be interpreted as the probability of vector still being in the infected class at infection age s. Then by similar argument above, we also obtain
Upon plugging in the boundary and initial conditions of (2.4) and (2.5) to (3.3) and (3.5), respectively, we obtain a system of integro-differential equations. Utilizing contraction mapping arguments, similar to methods in [18, 43] , the existence of unique solutions to the coupled system (2.4)-(2.5) can be shown, which remain non-negative for any time t.
After adding all equations in the system (2.4)-(2.5), we obtain
Thus solutions remain bounded for all time t and are attracted to a bounded set as t → ∞. Furthermore, solutions to the system (2.4)-(2.5) form a C 0 -semigroup, denoted Ψ(t), in the state space [39] . In particular, for x ∈ X, where φ(t) = Ψ(t)x denotes solution with initial condition x (written above), the following holds:
The long term behavior of the solutions is determined in part by the equilibria that are time-independent solutions of the system (2.4)-(2.5). The system (2.4)-(2.5) has a DFE
Define the reproduction number as follows:
The basic reproduction number R 0 keeps track of the number of secondary infectious hosts produced by one infected host during its infectious time period in an entirely sus-
is the average number of secondary infectious vectors produced one infectious host (whom is bitten by an infectious vector at infection age s) during its lifespan in a wholly susceptible vector population. In addition, e −dτ is the probability of host having survived to infection age τ.
Proof. To study the behavior of the solutions nearby an equilibrium, we first linearize the vector-host model
We look for eigenvalues of the linear operatorthat is we look for solutions of the form
y v are arbitrary non-zero constants (a function of τ or s in the case of y i for i ∈ {H, v}). This process results in the following system (the bars have been omitted):
Solutions of the system (3.8) give the eigenvectors and eigenvalues λ of the differential operator.
As in [27] , it can be shown that knowing the distribution of the eigenvalues is sufficient to determine the stability of a given equilibrium for PDEs operators. In other words, as similar to ODEs, if all eigenvalues have negative real parts, the corresponding equilibrium is locally stable; if there is an eigenvalue with a positive real part, then the equilibrium is unstable.
Because of that, we will concentrate on investigating eigenvalues.
Equilibrium of interest is DFE E 0 = (S 0 H , 0, 0, S 0 v , 0). Hence the system (3.8) simplifies to the following system:
Solving the differential equations in the linearized system (3.9), we obtain
Also by the boundary conditions in (3.9), we have
Substituting (3.10) and (3.12) into (3.11) and canceling y v (0), we get the following characteristic equation for λ : 
Notice that G(0) = R 0 . If R 0 > 1 and β H (τ, s) is strictly positive on a positive interval, then the function G(λ) is a decreasing function of λ. Since G(0) > 1 and lim λ→∞ G(λ) = 0, then there exists λ + > 0 : G(λ + ) = 1. Hence the DFE is unstable. Now let R 0 < 1. Then for all λ = a + ib with a ≥ 0, we have
Then λ's whose real part is non-negative can not satisfy the equation G(λ) = 1. Therefore the DFE is locally asymptotically stable in this case.
Under certain conditions, this result can be extended to global stability of E 0 by means of Lyapunov functions.
Then the DFE E 0 is globally asymptotically stable.
Proof. First define the positive functions
Then by Leibiniz rule, the derivatives of α(s) with respect to s and ω(τ, s) with respect to τ satisfy
with the non-negative initial data. We define a function W (t) as follows:
(by integration by parts)
Therefore the derivative of W along solutions is:
Therefore R v ≤ 1 and R H ≤ 1 ensures thatẆ ≤ 0 holds. Note that the within-host infection eventually clears (Theorem 1), implying that there is a finite maximum age of host-vector transmission. Also the within-vector viral load converges to equilibrium, implying that transmission rate β v (s) and inoculum h(V (s, V h→v 0 )) are eventually constant, allowing us essentially to separate solutions into a part with variable rates dependent on s for s < s M and constant rates for s > s M . These two features ensure a finite maximum age (so that all forward paths have compact closure), and allow us to apply Lyapunov-Lasalle Invariance Principle for functional differential equations [21] . Thus solutions tend to the largest invariant set, A, whereẆ = 0. Equality requires that S H (t) = S 0 We remark that R 0 ≤ R v R H by Hölder's inequality. The interpretation of R v is the average secondary host transmissions due to an infected vector, and for R H , the expected secondary vector transmissions by an infected host maximized over all possible vector to host inoculum sizes, V (s, V h→v 0 ). The result guarantees when both are less than unity, the disease eradicates.
Proof. Recall the solutions of the system (2.4)-(2.5) obtained along the characteristic lines:
Substituting (3.15) in the first equation in (2.5), and noting that
Now, define lim sup 
π H (τ, s)dτ ds
Proof. To find the endemic equilibria, we look for time-independent solutions with at least one non-zero infected compartment, which satisfy the system (2.4)-(2.5) with the time derivatives equal to zero:
An endemic equilibrium will be given by a non-trivial solution (S + H ,ī H (τ, s), R + H , S + v ,ī v (s)). We first solve the differential equations in the system (3.17) and obtain the following implicit solutions:
Substituting this expression into the vector boundary condition in (3.17) and cancelinḡ
Then the susceptible host equilibrium is:
From the third equation in (3.17), we can express R + H in the terms ofī v (0) :
Integrating the second differential equation in (3.17), we obtain
where lim τ →∞īH (τ, s) = 0. Adding this equation to the first and the fourth equations in (3.17), we obtain the population size for the host at equilibrium as follows:
Next, we substitute (3.22) Next we will solve the equation (3.23) forī v (0). Notice that by having an explicit expression forī v (0), we can obtainī H (τ, s). From the equation (3.23), we have
By the fourth equation in (3.17), we have the susceptible vector equilibrium as follows:
Substituting (3.25) into the equation (3.24) and rearranging it, we obtain
π H (τ, s)dτ ds (3.26)
Rearranging the equation (3.26), we get
Therefore whenever R 0 > 1,ī v (0) is positive, establishing the result. 
which is in terms of y H (τ, s), and λ. Then substituting this equality also in the last equation in (3.8), we obtain the last equality in the terms of x H , y v (0, t) and λ. We obtain the following system:
Since x H (t) = 0 and y v (0, t) = 0, we set the determinant below equal to zero
Notice that T ≥ 0. We obtain the following characteristic equation:
Then after cancelling some terms and rearranging (3.28), we obtain the following characteristic equation:
). Now by the way of contradiction, suppose that the characteristic equation (3.29) can have a solution λ with positive real part. Let λ = a + bi and assume a ≥ 0. Taking the absolute value of both side of the equality above, we get
Notice that
For λ with nonnegative real part, the LHS of the inequality remains strictly greater than one, while the RHS is strictly smaller than one. Thus, such λ's cannot satisfy the characteristic equation (3.29) . Hence the endemic equilibrium is locally asymptotically stable whenever it exists.
However the stability of E + when R 0 > 1, for general case, is unknown. The interesting question is: Is it possible that the heterogeneity among the vector infectivity destabilizes the endemic equilibrium, leading to oscillatory dynamics via Hopf bifurcation? From dynamical systems view, it is not uncommon that while structured PDE models can present oscillatory dynamics, but not a special case of it; for instance the ODE version of the system, where the model parameters are constant [3] . The characteristic equation (3.28) is too complicated for analysis to infer existence of a Hopf bifurcation, but future work will explore the possibility.
In the presence of a disease, one also would like to understand under what conditions the disease will remain endemic for large time. We say the disease is uniformly weakly endemic if there exists someε > 0 independent of the initial conditions such that . Then if R 0 > 1, then disease is uniformly weakly endemic.
Proof. By the way of contradiction, assume that there exists a solution I H (t), with I H (0) > 0, such that lim t→∞ I H (t) = 0. Let ε 1 > 0 be given. Then ∃t 0 > 0 :
Consequently, the semigroup properties of a solution (3.6) imply that without loss of generality we can assume the above inequality valid for all t ≥ 0. Next note that
for some positive real number K, since β H (τ ) ≤ a 0 (:=β H ) and lim sup
Then by the third equation of the system (2.4),
Then lim sup t→∞ R H (t) ≤γ ε 1 d . Hence by the inequality above, we have R H (t) ≤γ
for given δ 0 > 0 and ∀ t ≥ 0, by semigroup property. By similar argument above, we also obtain lim sup
Next by the first and fourth equation in the system (2.4)-(2.5), we obtain
Since the functions defined above are continuous and lim ε j →0 S 0 i (ε j ) = S 0 i , i ∈ {v, H}, j ∈ {1, 2}, it follows that for given ε 3 > 0, ∃t 1 : S i (t) ≥ S 0 i − ε 3 for i ∈ {v, H}, and ∀t ≥ t 1 . Again by semigroup property, w.l.o.g. the inequality above is valid for all 
Next note that by the equation (3.5), we have
). Thus we can write (3.32) in the following form:
R 0 as ε 3 0. Therefore, since R 0 > 1, for sufficiently small 3 , and by comparison principle applied to (3.33) , I H (t), I v (t) goes to infinity, as t → ∞. This is a contradiction to boundedness of solutions.
Here we conjecture that, for general case, R 0 > 1 implies uniform persistence of disease, and preserve it as future work. We turn our attention to crucial extensions of this modeling framework, and epidemiological implications.
The signatures of within-vector viral kinetics on disease dynamics
An interesting question is: Is it possible that infectiousness of mosquitoes can be a good predictor of disease outbreaks? In a recent study, Churcher et al. [6] found that the amount of parasites in a mosquito's salivary glands not only is a good indicator for how much the mosquito bite can be infectious, and also how faster infection would develop within-host upon receiving the bite. Therefore it is crucial to understand how the withinvector viral kinetics can be scaled up to the disease dynamics among host population for prediction and disease intervention. In previous section, we show that the basic reproduction number, R 0 , is a threshold quantity, providing whether a disease can persist or eventually die out. To numerically calculate the initial transmission risk R 0 , we first compute the probability function π H (τ, s), depending on the within-host model (2.2) variables, with initial condition, vector to host inoculum size P v→h . Here, we consider the host to vector inoculum size, V h→v 0 , to be constant, representing the mean. Then by implementing trapezoidal rule multiple times with chosen fixed time step size ∆τ = 0.0005, we estimated R 0 and the steady state disease abundanceĪ H (host) andĪ v (vector population) (see Fig.3 ). For numerical simulations, we obtain the value of within-host virus-immune response model and epidemiological parameters from the literature, presented in Tables 6, 7 , and 8, respectively. To estimate the within-vector parameters, we extracted within-mosquito WNV viral data, given in [12] , by using MATLAB code grabit.m, and numerically fit these data by using the least square error. Fig.2 displays the fitted model solution and the within-mosquito viral data (blue dots) given in [12] . The fitted parameter values are: r v = 0.3258, K v = 1.2303 × 10 3 , U v = 0.9933. Prior field studies suggest that environmental factors can manipulate the mosquito's competence [37, 2] . For example, it has been shown that as temperature increases, virus replication increases in a mosquito's tissues; therefore increasing viral replication withinmosquito and viral transmission to host. Some of the observed effects of temperature, it is suggested, are due to increased viral replication at higher temperatures that often results in a shortening of the EIP (the time it takes for a mosquito to become infectious once it has taken a viremic blood meal). In addition, it is revealed that the host to vector inoculum size and the length of the exposed period influence the effect of WNV transmission by Cx. nigripalpus [2] . However the impact of these factors on disease dynamics is still unclear. In Fig.3 , we vary the value of within-vector viral growth rate as r v = 0.1 (orange line), r v = 0.5 (green line), r v = 1 (blue line), and plot the corresponding values of basic reproduction number for distinct values of within-host viral growth rate r h ∈ [0.01, 7], and ask: How does the effect of external factors such as temperature can be scaled up to host population level disease transmission? The inserted subfigures in Fig.3 displays the corresponding within-vector viral dynamics with respect to varying values of the vector parameter r v (right), and the within-host viral-immune response antibody dynamics for r h = 7. and P v→h 0 = 0.01. We observe that increasing value of r v shortens virus incubation period for vectors, mimicking field studies, mentioned above [37] . Our numerical results suggest that in return, at host population scale, these mechanisms may lead to significant increase in initial transmission risks, R 0 . The biological insight is that increasing viral replication rates inside the mosquito decreases the time needed for a blood-fed mosquito to be able to pass on the virus to another host [8, 36, 32] . For example, in Fig.3 , an increase in within-vector parasite growth rate r v from 0.5 to 1, shortens the incubation period for 4 days (see inserted left figure), and increases the epidemic (disease persistence) parameter range of r h (R 0 > 1) from [0. 15 3.9 ] to [0. 14 4.68] . Therefore these results demonstrate that in an environment where disease may not persist due low susceptibility of host population (lower r h ), an increase in withinvector viral replication rate r v via external factors may lead prolonged epidemic (disease persistence). For instance, in an environment, where a resident mosquito population has a mean value of r v = 0.5, the disease only persists when within-host viral growth rate r h is in the parameter range [0. 15 3.9] . However when within-vector parasite growth rate is increased to r v = 1, this range increases to [0. 14 4.68] , implying that the infectivity of vector population can make host population more susceptible to epidemics. Therefore within-vector viral kinetics (whether it is manipulated by external factors or not) can change the fate of the disease outcomes, and might be a good predictor for disease outbreaks.
In Fig.4 , we also assess how the initial transmission risk, R 0 , changes across the distinct values of V h→v 0 and the within-host immune response parameter for a. The numerical results suggest that when the immune activation parameter a is small; i.e. when host population does not have strong immunity or protection against infection, the disease dynamics is very sensitive to host population infectivity. This implies that the impact of host to vector inoculum size V h→v 0 on the disease dynamics among the host population is more magnified in a host population with low immune profile. When there is no sufficient host immune response, larger V h→v 0 increases the probability of the parasite transmission from host to vector, in return increases the transmission risk among the host population significantly. These findings could have significant implications for public health, magnifying importance of control strategies such as drug treatment or vaccination, which can be utilized to slow down the viral production within-host scale. Another crucial motivation for considering within-vector viral dynamics explicitly in a tractable system is to assess the impact of vector to host inoculum size on the efficacy of control strategies. For example, the recent evidence suggests that the vaccine was less effective when mice or humans were bitten by mosquitoes carrying a greater number of parasites. Assuming that vaccination mainly works by increasing the withinhost immune response activation rates a, (or b), our results (mentioned above) mimic the observations from the field studies as follows: larger host to vector inoculum size V h→v 0 results in shorter vector exposed period (see left inserted subfigure in Fig.4) , and subsequently generates infectious vector distribution with larger inoculum size P v→h 0 .
Among host population with low immune state, this resulting increase in P v→h 0 causes larger vector to host virus transmission, ultimately leading an increase in the number of secondary cases (R 0 ). The biological insight behind of these findings from field studies is that because the vaccine can only kill a certain proportion of the parasites, it is overwhelmed when the parasite population is too large, suggesting that "it will become epidemiologically important to know how infected a mosquito is for disease elimination". One drawback of our model (2.4-2.5) is that the host to vector inoculum size V h→v 0 is chosen to be constant, representing the mean. Indeed it should also depend on the within-host viral load P (τ, s). Next we argue the motivation and challenges in overcoming this strain, and develop a feasible way to vary the host to vector inoculum size V h→v 0 , depending on host infectiousness. Recall that in our model, vector to host inoculum size depends on within-vector pathogen dynamics; i.e. P v→h 0 = h(V (s, V v→h 0 )), but host to vector inoculum size is assumed to be constant, V v→h 0 = P 0 .
4.1.
Incorporating two-way feedback between epidemiological and immunological scales. Mosquito vectors are often exposed to hosts that individually vary in pathogen loads, which can result in variation in the proportion of the mosquito population that becomes infectious. Although recent immuno-epidemiological models [20, 41] have been successful in measuring host to vector transmission as a function of withinhost viral load, in these models the varying within-host pathogen loads only implicitly affect the number of secondary infectious cases, where impact of host to vector inoculum size cannot be studied explicitly. Here we introduce a feasible way to incorporate host to vector inoculum size V h→v Fig.5 ). Yet, due to the significant mathematical complexity of a two-way "infinite-dimensional" feedback, closing the loop is not feasible. Next we describe a feasible way to improve this limitation. In contrast to previous attempts of incorporating feedback between scales [15] , our approach is amenable to analysis and biologically relevant for vector-borne diseases. To define the distribution, we assume that the probability distribution of V h→v 0 depend on two factors: (i) the amount of pathogen that a susceptible vector might get upon biting an infected host, depending on the host infectiousness β H (P (τ, s), P v→h 0 ) and (ii) the infected host densityī H (τ, s, P v→h 0 ). Therefore, we consider a distributed V h→v 0 , depending on within-host dynamics, given by (2.2), and the corresponding steady state infected host density,ī H (τ, s, P v→h 0 ), given by (3.17), as follows:
Then the system has the basic reproduction number as follows:
The Fig. 6(a) displays the distribution of host to vector inoculum size with respect to varying within-vector viral growth rate r v . The Fig. 6 (b) displays how R 0 changes w.r.t. varying r v , given how infectious the host population is, which is defined by the range of V h→v 0 . Numerical results suggest that in a highly infectious host population (larger inoculum size range: V h→v 0 ∈ [0.01 2]), increasing within-vector viral growth rate r v increases initial transmission risk, R 0 . However, an increase in r v among a less infectious host population (inoculum size V h→v 0 ∈ [0.01 1]) decreases R 0 , suggesting that when the host population is less infectious due to resulting distribution p(V h→v 0 ), vectors as intermediate carries only dilute the effect of disease transmission due to Allee effect. These findings could have significant implications for disease control. Our numerical results highlight that: (i) a significant reduction in host to vector inoculum size, which can be accomplish utilizing a drug treatment or vaccination (to hamper virus transmission from host to vector) can reduce R 0 , significantly, in which case the disease can be ultimately eradicated (see Fig.6 ), (ii) when host population is very infectious, vector infectivity magnifies the disease outcomes. A more rigorous approach in assessing the impact of vector, or host parameters on disease dynamics requires investigating the sensitivity of within-vector viral kinetics, within-host immune response and epidemic parameters to R 0 , and E + which we reserve as a future work.
Conclusion
Within-vector viral dynamics can be a driving mechanism in disease dynamics and vector-borne pathogen evolution. Assessing the impact of within-vector viral kinetics on disease dynamics at population scale requires tractable models to measure this impact. In this study, we develop a multi-scale vector-borne disease model, connecting all scales from within-vector viral kinetics to between vector-host disease spread. By doing so, we investigate the impact of within-vector viral kinetics on disease dynamics and, in particular, address:
(i) How host and vector infectivity, measured by inoculum size, might affect the landscape of the initial transmission risks, R 0 . (ii) And how within-host immune response combined with within-vector viral kinetics might affect the success of a control strategy such as vaccination, and drug treatment. There are several reasons for explicitly modeling the heterogeneity in the within-vector dynamics in the novel manner of this work. First the overall aim is to construct a multiscale model so variations in parameters associated with within-vector viral kinetics can be extrapolated to the overall epidemic dynamics. These variations may come from climate or environmental factors, or bio-control strategies such as Wolbachia, and the within-vector viral model can be validated directly from experiment. Tracking dynamics within vectors, as opposed to using average quantities for vector epidemiological parameters (as in ODE models), allows for important biological and mathematical features to be captured. For instance, the delay between infecting bite and viral growth to infectious levels within the mosquito, known as extrinsic incubation period (EIP), can be a very sensitive quantity for determining disease spread [40] . While a delay differential equation (DDE) can be used and is also a special case of the PDE, a DDE will still not capture all of the heterogeneity levels of infectiousness that this model. Furthermore, our multi-scale framework provides a natural way to have within-vector parameters shape the EIP, and, in turn, the overall epidemic, as exemplified in Fig. 3 where within-vector viral growth rate can largely affect R 0 .
In addition, a goal of this work is to model how vector-to-host inoculum size affects the dynamics. In previous work [20] , we showed that this inoculum size, as a parameter, has a very large effect on virulence evolution for vector-borne diseases. Here by also incorporating vector viral infection kinetics, we can directly model variable inoculum size based on the within-vector dynamics determining both infectiousness and the initial condition in our within-host model which has a large impact on the host infection, as observed in Fig. 4 .
For analytical results, upon defining the basic reproduction number, R 0 , (depending on host and vector infectious status), we prove that if R 0 < 1, the disease-free equilibrium E 0 is locally (via linearization) and globally asymptotically stable (via comparision principle). Otherwise if R 0 > 1, the system has a unique endemic equilibrium, E † , and it is locally asymptotically stable when the vector to host inoculum size, P v→h 0 , is constant during vector infectious time period. However, for general case, the stability of E † , might not be guaranteed via standard linearization method. We provide a condition that if holds, the system might present a Hopf bifurcation, leading oscillatory dynamics. Given the constant vector to host inoculum size, we also show that whenever R 0 > 1, the disease is uniformly weakly persistent.
Our numerical results suggest that when immune response is very low among host population, or when vaccination do not provide sufficiently large immunity, the disease transmission between and within-host are very sensitive to vector to host inoculum size P v→h 0 , mimicking field studies. Indeed, recent field studies suggest that when mosquitoes were very infectious (large vector to host inoculum size), the vaccine was less effective when mice or humans were bitten by mosquitoes carrying a greater number of Malaria parasites, due to "overwhelmed" immune response. Therefore the within-vector viral kinetics, providing how infectious mosquito population, can be crucial determining the transmission risk, and it can impact the outcomes of disease control strategies such as vaccination. In addition, we extend this model by incorporating a distribution of host to vector inoculum size V h→v 0 . Our results suggest that in a highly infectious host population, the disease outbreaks are highly sensitive to vector competence, magnifying the importance of disease control strategies such as drug treatment, and vaccination, which can slow down the viral progression within-hosts.
In conclusion, in this paper, we develop an immuno-epidemiological model, coupling within-vector viral kinetics, within-host virus-immune response and between host -vector disease transmission. As one of the crucial applications, we show that the developed multi-scale model can be utilized to assess the impact of disease control strategies, when the infectiousness of host population and vector population vary across scales. We also investigate how environmental factors such as temperature can magnify the role of vectors in disease outcomes. Field studies also suggest that nutrition and competition during the larval stage may also influence the transmission capability of arboviruses for the resulting adult females. In addition, environmental factors such as exposure to insecticides in the adult or larval stages has been shown to influence mosquito competence for arboviruses [28, 46, 28] . Future work will investigate the role of these mechanisms on disease dynamics. In addition in host scale, we only consider adaptive, but not innate immune response, which might affect the disease outcomes. Future work will include these complexities. The multi-scale modelling framework, introduced here, can be utilized to assess the role of vectors on disease dynamics, given many external factors affecting the vector competence and host immune response. In addition, it can be used for assessing the impact of Wolbachia-based biocontrol strategy, mainly utilized to interfere within-vector viral growth to slow down disease transmission among host population, which will be the future work. In summary, the modeling work contained in this paper can help to understand the effect of within-vector viral kinetics on arbovirus disease dynamics and help to guide policies on strategies for disease control. 
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